You are here

  • Home
  • Archive
  • Volume 4, Issue 2
  • Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk

Article metrics

Article menu

Download PDFPDF

XML
Editorial
Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk

 

Online download statistics by month:

Online download statistics by month: November 2017 to May 2022

AbstractFullPdf
Nov 20176156183887
Dec 20173573583238
Jan 2018440440859
Feb 2018174170455
Mar 2018186189275
Apr 2018127127162
May 2018161162122
Jun 2018119121104
Jul 2018107107110
Aug 2018204203139
Sep 2018314314155
Oct 2018274275145
Nov 2018315315125
Dec 201826726798
Jan 2019245243191
Feb 2019279279183
Mar 2019382382202
Apr 2019528523192
May 2019470469193
Jun 2019452451166
Jul 2019514515205
Aug 2019512512186
Sep 2019485486212
Oct 2019499499109
Nov 201950149871
Dec 201943243240
Jan 202048648644
Feb 202045645657
Mar 202036036046
Apr 202020620627
May 202021721759
Jun 202020720531
Jul 202025925437
Aug 202019519327
Sep 202024123939
Oct 202035535048
Nov 202029329247
Dec 202035634849
Jan 202135834549
Feb 202135334545
Mar 202139238540
Apr 202132131649
May 202130329359
Jun 202131531345
Jul 202140740450
Aug 202131531145
Sep 202133433053
Oct 202137736789
Nov 202122421747
Dec 202145445756
Jan 202233633755
Feb 202231331941
Mar 202239440863
Apr 202243844752
May 202231632643
Total185401848113216